Indian Council of Medical Research

Hyderabad andhra Pradesh, India

Indian Council of Medical Research

Hyderabad andhra Pradesh, India

Time filter

Source Type

Patent
Indian Council Of Medical Research, Birla Institute of Technology and Science | Date: 2015-06-18

This invention relates to a test strip for holding reagents to determine blood glucose level, said strip comprising a) a plasma separator membrane which is a composite membrane for separation of plasma from whole blood, said plasma separator membrane containing an enzyme mix specific to the analyte, said analyte being glucose, a substrate which reacts specifically with one of the products of the enzymatic reaction of the analyte with the enzyme mix, b) a reaction membrane containing an enhancer mix of metallic ions, which enhances the color developed due to the enzymatic reaction.


Patent
Indian Council Of Medical Research, Birla Institute of Technology and Science | Date: 2017-04-26

This invention relates to a test strip for holding reagents to determine blood glucose level, said strip comprising a) a plasma separator membrane which is a composite membrane for separation of plasma from whole blood, said plasma separator membrane containing an enzyme mix specific to the analyte, said analyte being glucose, a substrate which reacts specifically with one of the products of the enzymatic reaction of the analyte with the enzyme mix, b) a reaction membrane containing an enhancer mix of metallic ions, which enhances the color developed due to the enzymatic reaction.


This invention relates to a thermoluminescent phosphor for the measurement of low radiation doses, including calcium sulphate (CaSO_(4)), Dysprosium (Dy) and manganese (Mn), wherein Dy and Mn are present as dopants. A process for the preparation of a thermoluminescent phosphor is also provided. The process includes the steps of: separately dissolving calcium sulphate (CaSO4), Dysprosium chloride (DyCh) and Manganese chloride (MnC) in hot concentrated sulphuric acid, to obtain sulphuric acid solutions of CaSO4, DyCb and MnCb; mixing the solutions; and followed by slow evaporation of the solvent to obtain a powder of microcrystalline phosphor of CaSO4:Dy, Mn.


Patent
Indian Council Of Medical Research | Date: 2014-04-25

This invention relates to a culture medium for cultivation of Leishmania promastigotes, comprising inorganic salts, organic constituents and peptone/hydrolystate and at least one plant extract.


Patent
Indian Council Of Medical Research | Date: 2014-01-09

Provided herein is a compound represented by Formula (I) (Transitmycin) effective against bacterial and viral pathogens.


Patent
Indian Council Of Medical Research | Date: 2014-05-05

Provided herein is a drug delivery system for curcumin comprising fibrinogen, thrombin and curcumin.


Patent
Sree Chitra Tirunal Institute for Medical Science, Technology and Indian Council Of Medical Research | Date: 2014-05-20

This invention relates to an albumin-curcumin conjugate for application in cancer therapy, including albumin and curcumin.


Patent
Indian Council Of Medical Research and The King's University | Date: 2014-03-04

Provided herein are primers and probes for the detection of Hepatitis B virus and Hepatitis C virus in a sample, a reaction mixture for multiplex real time PCR for the simultaneous detection and quantitation of Hepatitis B and C and a test kit based on multiplex real time PCR for the simultaneous detection and quantitation of Hepatitis B and C.


Provided herein is a process for the production of Cyclosporin-A (Cyc-A) including the steps of inoculating a nutrient medium with the fungus Tolypocladium sp., strain NRRL No. 18950 followed by cultivation under static conditions to obtain a fermented medium with the fungal biomass, and harvesting the biomass and subjecting the harvested biomass to extraction followed by purification to obtain pure Cyc-A. The nutrient medium includes glucose, glycerol, casein acid hydro lysate, malt extract, peptone, and L-valine.


Patent
Indian Council Of Medical Research | Date: 2014-07-02

Provided herein are RNAi agents for inhibition of Chikungunya virus. The present disclosure provides RNAi agents for inhibition of Chikungunya virus, particularly by targeting the E2 gene and nsP1 gene or both of the Chikungunya virus; the RNAi agents comprising of the entire nucleotide sequence set forth is SEQ ID 1 or SEQ ID 5 or combination thereof; or comprising of 15 or more contiguous nucleotides as set forth is SEQ ID 1 or SEQ ID 5 or combination thereof along with the addition nucleotides from the contiguous region of the E2 and nsP1 target gene. The invention further provides a RNAi composition for reducing the E2 protein and nsP1 protein level of Chikungunya virus and inhibition of Chikungunya virus replication. The combination of RNAi agents provides an excellent therapeutic composition for treatment of Chikungunya virus infection.

Loading Indian Council of Medical Research collaborators
Loading Indian Council of Medical Research collaborators